SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-009896
Filing Date
2016-05-16
Accepted
2016-05-16 16:11:56
Documents
55
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 514526
2 ex31-1.htm EX-31.1 33283
3 ex32-1.htm EX-32.1 6476
  Complete submission text file 0001493152-16-009896.txt   2929897

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE imnp-20160331.xml EX-101.INS 466175
5 XBRL SCHEMA FILE imnp-20160331.xsd EX-101.SCH 48692
6 XBRL CALCULATION FILE imnp-20160331_cal.xml EX-101.CAL 40254
7 XBRL DEFINITION FILE imnp-20160331_def.xml EX-101.DEF 113177
8 XBRL LABEL FILE imnp-20160331_lab.xml EX-101.LAB 271889
9 XBRL PRESENTATION FILE imnp-20160331_pre.xml EX-101.PRE 189422
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 161653877
SIC: 2834 Pharmaceutical Preparations